BioCardia, Inc. IPO Research Information

BioCardia, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on BioCardia, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
BioCardia, Inc.	BCDA - NASDAQ	TBD	$0.00	$0.00	3.8 million
Underwriter(s): Cantor Fitzgerald & Co.
Co-Manager(s): Roth Capital Partners, Maxim Group LLC
Industry:
Filing(s): Filed 2015-06-16 Terms Added 2015-07-06

About BioCardia, Inc. (adapted from BioCardia, Inc. prospectus):
They are a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "BCDA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.